Chemoinformaics analysis of 4-Hydroxybenzaldehyde
| Molecular Weight | 122.123 | nRot | 1 |
| Heavy Atom Molecular Weight | 116.075 | nRig | 17 |
| Exact Molecular Weight | 122.037 | nRing | 1 |
| Solubility: LogS | -5.008 | nHRing | 0 |
| Solubility: LogP | 4.751 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 17.2948 |
| nHD | 1 | BPOL | 6.88724 |
| QED | 0.698 |
| Synth | 4.337 |
| Natural Product Likeliness | 3.112 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.655 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.733 |
| MDCK | 0.00000877 |
| BBB | 0.192 |
| PPB | 0.961743 |
| VDSS | 2.292 |
| FU | 0.0245369 |
| CYP1A2-inh | 0.181 |
| CYP1A2-sub | 0.769 |
| CYP2c19-inh | 0.219 |
| CYP2c19-sub | 0.938 |
| CYP2c9-inh | 0.194 |
| CYP2c9-sub | 0.257 |
| CYP2d6-inh | 0.494 |
| CYP2d6-sub | 0.669 |
| CYP3a4-inh | 0.48 |
| CYP3a4-sub | 0.684 |
| CL | 11.832 |
| T12 | 0.224 |
| hERG | 0.013 |
| Ames | 0.028 |
| ROA | 0.086 |
| SkinSen | 0.583 |
| Carcinogencity | 0.085 |
| EI | 0.101 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.148 |
| Antiviral | No |
| Prediction | 0.868446 |